Detailed Information on Publication Record
2019
Clinical and Functional Characterization of a Novel URAT1 Dysfunctional Variant in a Pediatric Patient with Renal Hypouricemia
STIBURKOVA, Blanka, Jana BOHATA, Iveta MINARIKOVA, Andrea MANCIKOVA, Jiri VAVRA et. al.Basic information
Original name
Clinical and Functional Characterization of a Novel URAT1 Dysfunctional Variant in a Pediatric Patient with Renal Hypouricemia
Authors
STIBURKOVA, Blanka (203 Czech Republic, guarantor), Jana BOHATA (203 Czech Republic), Iveta MINARIKOVA (203 Czech Republic), Andrea MANCIKOVA (203 Czech Republic), Jiri VAVRA (203 Czech Republic), Vladimir KRYLOV (203 Czech Republic) and Zdeněk DOLEŽEL (203 Czech Republic, belonging to the institution)
Edition
Applied Sciences-Basel, BASEL, MDPI, 2019, 2076-3417
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30217 Urology and nephrology
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 2.474
RIV identification code
RIV/00216224:14110/19:00110982
Organization unit
Faculty of Medicine
UT WoS
000488603600041
Keywords in English
SLC22A12; URAT1; hypouricemia; uric acid transporters; excretion fraction of uric acid
Tags
International impact, Reviewed
Změněno: 17/2/2020 10:52, Mgr. Tereza Miškechová
Abstract
V originále
Renal hypouricemia (RHUC) is caused by an inherited defect in the main (reabsorptive) renal urate transporters, URAT1 and GLUT9. RHUC is characterized by decreased concentrations of serum uric acid and an increase in its excretion fraction. Patients suffer from hypouricemia, hyperuricosuria, urolithiasis, and even acute kidney injury. We report the clinical, biochemical, and genetic findings of a pediatric patient with hypouricemia. Sequencing analysis of the coding region of SLC22A12 and SLC2A9 and a functional study of a novel RHUC1 variant in the Xenopus expression system were performed. The proband showed persistent hypouricemia (67-70 mu mol/L; ref. range 120-360 mu mol/L) and hyperuricosuria (24-34%; ref. range 7.3 +/- 1.3%). The sequencing analysis identified common non-synonymous allelic variants c.73G > A, c.844G > A, c.1049C > T in the SLC2A9 gene and rare variants c.973C > T, c.1300C > T in the SLC22A12 gene. Functional characterization of the novel RHUC associated c.973C > T (p. R325W) variant showed significantly decreased urate uptake, an irregular URAT1 signal on the plasma membrane, and reduced cytoplasmic staining. RHUC is an underdiagnosed disorder and unexplained hypouricemia warrants detailed metabolic and genetic investigations. A greater awareness of URAT1 and GLUT9 deficiency by primary care physicians, nephrologists, and urologists is crucial for identifying the disorder.